Lista de obras - Hojjat Ahmadzadehfar - Dominio Público Uruguay

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

artículo científico publicado en 2017

177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response.

artículo científico publicado en 2016

68Ga-Labeled Anti-Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer

artículo científico publicado en 2016

68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer

artículo científico publicado en 2016

90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy

artículo científico publicado en 2012

99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization

artículo científico publicado en 2011

Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate.

artículo científico publicado en 2013

Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion

artículo científico publicado en 2018

Appearance of extraosseous pelvic Ewing sarcoma on triphasic bone scan

artículo científico publicado en 2014

Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT.

artículo científico publicado en 2017

Bone erosion due to aortic prosthesis by 18F-FDG-PET/CT.

artículo científico publicado en 2011

Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement

artículo científico publicado en 2014

Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer

artículo científico publicado en 2017

Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma

artículo científico publicado en 2013

Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules.

artículo científico publicado en 2017

Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy

scientific article published on 01 October 2013

Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?

artículo científico publicado en 2012

Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer

artículo científico publicado en 2009

Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate.

artículo científico publicado en 2013

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

artículo científico publicado en 2015

Early signs of VCP-related frontotemporal dementia: a neuropsychological, FDG-PET and fMRI study

scholarly article by Elke Kalbe et al published 12 October 2010 in Journal of Neurology

Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution

artículo científico publicado en 2015

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.

artículo científico publicado en 2006

False positive 18F-FDG-PET/CT in a patient after talc pleurodesis

artículo científico publicado en 2007

False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient

artículo científico publicado en 2010

Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours

artículo científico publicado en 2013

Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study

artículo científico publicado en 2012

Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy

artículo científico publicado en 2010

Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30.

artículo científico publicado en 2017

Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.

artículo científico publicado en 2015

Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer

artículo científico publicado en 2007

Incremental diagnostic value of SPET/CT in precise localization of extraskeletal uptake of bone-seeking agents in multiple myeloma

scientific article published on 01 September 2010

Iodine-131-lipiodol therapy in hepatic tumours.

artículo científico publicado en 2011

Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

scientific article published on 15 April 2011

It is time to move forward into the era of Theranostics.

artículo científico publicado en 2018

Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate

artículo científico publicado en 2013

Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors

artículo científico publicado en 2013

Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617.

artículo científico publicado en 2016

Neoadjuvant downsizing by internal radiation: a case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors.

artículo científico publicado en 2012

Osseous metastases of gastro-enteropancreatic neuroendocrine tumours. Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy

artículo científico publicado en 2012

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

artículo científico publicado en 2013

Passive cigarette smoking increases isoprostane formation.

artículo científico publicado en 2005

Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.

artículo científico publicado en 2016

Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617.

artículo científico publicado en 2017

Predictive Factors of Response and Overall Survival in Patients with Castration-Resistant Metastatic Prostate Cancer Undergoing 177Lu-PSMA Therapy

artículo científico publicado en 2018

Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate

artículo científico publicado en 2014

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.

artículo científico publicado en 2017

Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma

artículo científico publicado en 2008

Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

artículo científico publicado en 2011

Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.

artículo científico publicado en 2018

Quality of life in patients with midgut NET following peptide receptor radionuclide therapy

artículo científico publicado en 2019

Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels

artículo científico publicado en 2014

Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride.

artículo científico publicado en 2017

Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use.

artículo científico publicado en 2016

Radionuclide intake risks in the clinical administration of 223RaCl2

scientific article published on 04 February 2019

Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method

artículo científico publicado en 2013

Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

artículo científico publicado en 2011

Review: The role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma

artículo científico publicado en 2017

Role of high-resolution ultrasound and PET/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma.

artículo científico publicado en 2012

Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour.

artículo científico publicado en 2017

Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution

artículo científico publicado en 2012

Significance of multiple nodal basin drainage in patients with truncal melanoma

Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization

artículo científico publicado en 2011

Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.

artículo científico publicado en 2008

Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis.

artículo científico publicado en 2016

Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.

artículo científico publicado en 2016

Successful radiopeptide targeting of metastatic anaplastic meningioma: case report

artículo científico publicado en 2011

Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up

artículo científico publicado en 2014

Survival after accidental extrahepatic distribution of Y90 microspheres to the mesentery during a radioembolization procedure

artículo científico publicado en 2011

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation

artículo científico publicado en 2011

Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.

artículo científico publicado en 2014

The importance of Tc-MAA SPECT/CT for therapy planning of radioembolization in a patient treated with bevacizumab

scientific article published on 01 November 2012

The role of SPECT/CT in radioembolization of liver tumours.

artículo científico

The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment

artículo científico publicado en 2010

The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects

artículo científico publicado en 2011

The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

artículo científico publicado en 2016

Theranostics in nuclear medicine practice

artículo científico publicado en 2017

Thoracic (99m)Tc-MAA accumulations due to aberrant arteries originating from the phrenic artery

artículo científico publicado en 2016

Ultrasound detection of a PET/CT negative lymph node metastasis in cutaneous melanoma

artículo científico publicado en 2010

Unusual case of well-differentiated papillary thyroid carcinoma lacking thyroglobulin expression while still concentrating radioiodine

artículo científico publicado en 2006

Volumetric and scintigraphic changes following endoscopic lung volume reduction

artículo científico publicado en 2014

Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients

artículo científico publicado en 2013

Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience

artículo científico publicado en 2016

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma - a single center experience.

artículo científico publicado en 2017

[SPECT/CT: Benefit and indications of hybrid imaging]

artículo científico publicado en 2015

[Uniliteral wheezes as the first clinical sign of a bronchial carcinoid]

artículo científico publicado en 2010

Lista de obras de Hojjat Ahmadzadehfar

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response.

68Ga-Labeled Anti-Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer

68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer

90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy

99mTc-MAA/ 90Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/90Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization

Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate.

Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion

Appearance of extraosseous pelvic Ewing sarcoma on triphasic bone scan

Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT.

Bone erosion due to aortic prosthesis by 18F-FDG-PET/CT.

Can peptide receptor radionuclide therapy be safely applied in florid bone metastases? A pilot analysis of late stage osseous involvement

Combination of 177Lu-PSMA-617 and External Radiotherapy for the Treatment of Cerebral Metastases in Patients With Castration-Resistant Metastatic Prostate Cancer

Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma

Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules.

Diffusion-weighted imaging with acquisition of three b-values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy

Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?

Dual-time F-18 FDG-PET/CT imaging for diagnosis of occult non-Hodgkin lymphoma in a patient with esophageal cancer

Early prediction of tumour response to PRRT. The sequential change of tumour-absorbed doses during treatment with 177Lu-octreotate.

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

Early signs of VCP-related frontotemporal dementia: a neuropsychological, FDG-PET and fMRI study

Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.

False positive 18F-FDG-PET/CT in a patient after talc pleurodesis

False positive and false negative thyroid 99mTc-sestamibi scintigraphy in the same patient

Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours

Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study

Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy

Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30.

Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.

Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer

Incremental diagnostic value of SPET/CT in precise localization of extraskeletal uptake of bone-seeking agents in multiple myeloma

Iodine-131-lipiodol therapy in hepatic tumours.

Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

It is time to move forward into the era of Theranostics.

Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate

Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors

Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617.

Neoadjuvant downsizing by internal radiation: a case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors.

Osseous metastases of gastro-enteropancreatic neuroendocrine tumours. Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

Passive cigarette smoking increases isoprostane formation.

Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.

Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617.

Predictive Factors of Response and Overall Survival in Patients with Castration-Resistant Metastatic Prostate Cancer Undergoing 177Lu-PSMA Therapy

Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.

Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma

Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.

Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy.

Quality of life in patients with midgut NET following peptide receptor radionuclide therapy

Radioembolization with 90Y resin microspheres for HCC patients with extensive tumor thrombosis into the extrahepatic vessels

Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride.

Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use.

Radionuclide intake risks in the clinical administration of 223RaCl2

Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method

Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

Review: The role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma

Role of high-resolution ultrasound and PET/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma.

Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour.

Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution

Significance of multiple nodal basin drainage in patients with truncal melanoma

Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization

Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.

Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis.

Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.

Successful radiopeptide targeting of metastatic anaplastic meningioma: case report

Survival after 131I-labeled lipiodol therapy for hepatocellular carcinoma. A single-center study based on a long-term follow-up

Survival after accidental extrahepatic distribution of Y90 microspheres to the mesentery during a radioembolization procedure

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation

Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Prediction by 18F-FDG PET.

The importance of Tc-MAA SPECT/CT for therapy planning of radioembolization in a patient treated with bevacizumab

The role of SPECT/CT in radioembolization of liver tumours.

The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment

The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects

The value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases

Theranostics in nuclear medicine practice

Thoracic (99m)Tc-MAA accumulations due to aberrant arteries originating from the phrenic artery

Ultrasound detection of a PET/CT negative lymph node metastasis in cutaneous melanoma